Meeder Asset Management’s LeMaitre Vascular LMAT Stock Holding History

Meeder Asset Management’s Portfolio LMAT Stock Details LMAT Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2022 Q4	–	Sell	-283	Closed	-$14K	–	1461
2022 Q3	$14K	Buy	283 +14	+5%	+$700	﹤0.01%	1216
2022 Q2	$12K	Buy	269 +244	+976%	+$10.9K	﹤0.01%	1311
2022 Q1	$1K	Buy	+25	New	+$1.12K	﹤0.01%	2203
2021 Q4	–	Sell	-69	Closed	-$4K	–	1806
2021 Q3	$4K	Buy	69 +53	+331%	+$2.98K	﹤0.01%	2007
2021 Q2	$1K	Buy	16 +6	+60%	+$319	﹤0.01%	2358
2021 Q1	$0	Hold	10	–	–	﹤0.01%	2410
2020 Q4	$0	Hold	10	–	–	﹤0.01%	2055
2020 Q3	$0	Hold	10	–	–	﹤0.01%	2286
2020 Q2	$0	Buy	+10	New	+$261	﹤0.01%	2276
2019 Q3	–	Sell	-513	Closed	-$14K	–	2213
2019 Q2	$14K	Sell	513 -247	-33%	-$6.86K	﹤0.01%	1351
2019 Q1	$24K	Buy	+760	New	+$20.3K	﹤0.01%	1035
2018 Q1	–	Sell	-133	Closed	-$4K	–	1655
2017 Q4	$4K	Buy	+133	New	+$4.56K	﹤0.01%	1365

Other funds holding LMAT

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

CCA

Conestoga Capital Advisors Wayne, Pennsylvania $5.01B AUM 6.26% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

CCM

Copeland Capital Management Conshohocken, Pennsylvania $4.5B AUM 18.67% 1-Year Est. Return

RIM

Ranger Investment Management Dallas, Texas $1.38B AUM 24.55% 1-Year Est. Return

GCM

Geneva Capital Management Milwaukee, Wisconsin $4.71B AUM 6.32% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

CRM

Cramer Rosenthal McGlynn Stamford, Connecticut $1.36B AUM 31.72% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

KCM

Kennedy Capital Management St Louis, Missouri $4.72B AUM 36.69% 1-Year Est. Return

Meeder Asset Management's LMAT Position: Q4 2022 in Review

Meeder Asset Management sold out of LeMaitre Vascular (LMAT) in Q4 2022, closing a stake of 283 shares — an estimated $14K sold.

Meeder Asset Management first reported a position in LMAT in Q4 2017 and held it in 12 quarters. The position peaked at $24K in Q1 2019. 182 funds tracked by Wall St. Rank hold LMAT as of Q4 2022.

Meeder Asset Management reported no remaining LeMaitre Vascular position as of Q4 2022 after selling out during the quarter.
Meeder Asset Management sold 283 LeMaitre Vascular shares in Q4 2022, an estimated $14K.
Meeder Asset Management first reported a position in LeMaitre Vascular in Q4 2017 and held it in 12 quarters.
Meeder Asset Management's LeMaitre Vascular position peaked at $24K in Q1 2019.
182 funds tracked by Wall St. Rank held LeMaitre Vascular as of Q4 2022.

Based on Meeder Asset Management's 13F filing for Q4 2022, filed 14 Feb 2023.